And if the results are as we hope, and if they're similar to the Phase 2 studies, by the end of 2021, FDA will approve MDMA-assisted psychotherapy for PTSD.
i ako rezultati budu onakvi kakvima se nadamo, slični onima iz druge faze, do kraja 2021. će FDA odobriti  MDMA za PTSP.